Establishing Radiolanthanum Chemistry for Targeted Nuclear Medicine Applications.
Animals
Cell Line, Tumor
Contrast Media
/ chemistry
Heterocyclic Compounds, 1-Ring
/ chemistry
Humans
Lanthanum
/ chemistry
Male
Mice
Positron Emission Tomography Computed Tomography
Prostate-Specific Antigen
/ antagonists & inhibitors
Prostatic Neoplasms
/ diagnostic imaging
Radiopharmaceuticals
/ chemistry
Transplantation, Heterologous
imaging
lanthanum
positron emission tomography
radiochemistry
radiopharmaceuticals
Journal
Chemistry (Weinheim an der Bergstrasse, Germany)
ISSN: 1521-3765
Titre abrégé: Chemistry
Pays: Germany
ID NLM: 9513783
Informations de publication
Date de publication:
27 Jan 2020
27 Jan 2020
Historique:
received:
17
11
2019
pubmed:
20
11
2019
medline:
12
2
2020
entrez:
20
11
2019
Statut:
ppublish
Résumé
We report the first targeted nuclear medicine application of the lanthanum radionuclides
Identifiants
pubmed: 31743504
doi: 10.1002/chem.201905202
pmc: PMC7261199
mid: NIHMS1066027
doi:
Substances chimiques
Contrast Media
0
Heterocyclic Compounds, 1-Ring
0
Radiopharmaceuticals
0
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
1HTE449DGZ
Lanthanum
6I3K30563S
Prostate-Specific Antigen
EC 3.4.21.77
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1238-1242Subventions
Organisme : NIGMS NIH HHS
ID : T32 GM092714
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009206
Pays : United States
Organisme : NHLBI NIH HHS
ID : K99 HL125728
Pays : United States
Organisme : NCI NIH HHS
ID : T32CA009206
Pays : United States
Organisme : NIH HHS
ID : HL125728
Pays : United States
Organisme : NHLBI NIH HHS
ID : R00 HL125728
Pays : United States
Informations de copyright
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
Références
Mol Imaging Biol. 2015 Aug;17(4):565-74
pubmed: 25896814
Curr Radiopharm. 2018;11(3):200-208
pubmed: 29732998
J Labelled Comp Radiopharm. 2018 Mar;61(3):141-153
pubmed: 29143368
Bioconjug Chem. 2012 Apr 18;23(4):688-97
pubmed: 22369515
Chem Rev. 2019 Jan 23;119(2):870-901
pubmed: 30299088
EJNMMI Res. 2017 Dec;7(1):9
pubmed: 28102507
Chem Rev. 2019 Jan 23;119(2):902-956
pubmed: 30379537
J Nucl Med. 2015 Aug;56(8):1169-76
pubmed: 26089548
J Nucl Med. 2013 Aug;54(8):1369-76
pubmed: 23733925
Sci Rep. 2019 Jul 23;9(1):10658
pubmed: 31337833
Theranostics. 2016 Apr 12;6(6):849-61
pubmed: 27162555
Phys Med Biol. 2017 Dec 29;63(1):015026
pubmed: 29286003
Angew Chem Int Ed Engl. 2017 Nov 13;56(46):14712-14717
pubmed: 28963750
Inorg Chem. 2011 May 2;50(9):4125-41
pubmed: 21456610
Eur J Nucl Med Mol Imaging. 2012 Aug;39(8):1271-7
pubmed: 22526963
Chem Rev. 2013 Feb 13;113(2):858-83
pubmed: 23198879
Radiat Res. 2007 Jan;167(1):110-20
pubmed: 17214512
Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2125-35
pubmed: 21892623
J Am Chem Soc. 2009 Mar 11;131(9):3331-41
pubmed: 19256570
Adv Drug Deliv Rev. 2017 Jan 15;109:102-118
pubmed: 26705852